Rare diseases
Investigational molecules
Locations
Back to Croatia7 clinical trials in Dubrovnik, Croatia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)CroatiaCroatiaCroatiaCroatiaCroatiaCroatiaCroatiaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on non-small cell lung cancer (NSCLC) treatments, evaluating novel combination therapies and comparing their effectiveness to standard treatments.
Studies include investigations of triple therapy approaches for chronic obstructive pulmonary disease patients, aiming to reduce exacerbation rates.
Groundbreaking trials examining new therapeutic approaches for lung cancer, particularly focusing on immunotherapy combinations and targeted treatments.
Research emphasizes personalized treatment approaches based on specific biomarkers and patient characteristics.
Essential clinical research addressing atrial fibrillation and acute coronary syndrome, testing innovative therapeutic agents for better patient outcomes.
Trials focus on reducing recurrent cardiovascular events and improving long-term patient prognosis.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
